메뉴 건너뛰기




Volumn 56, Issue 2, 2018, Pages

Verification of ceftazidime-avibactam and ceftolozane-tazobactam susceptibility testing methods against carbapenem-resistant enterobacteriaceae and pseudomonas aeruginosa

Author keywords

Carbapenem resistant Enterobacteriaceae; Carbapenem resistant Pseudomonas; Ceftazidime avibactam resistance; Ceftolozane tazobactam resistance; Disk diffusion; Etest

Indexed keywords

ANTIINFECTIVE AGENT; AVIBACTAM, CEFTAZIDIME DRUG COMBINATION; AZABICYCLO DERIVATIVE; CEFTAZIDIME; CEFTOLOZANE, TAZOBACTAM DRUG COMBINATION; CEPHALOSPORIN DERIVATIVE; TAZOBACTAM;

EID: 85047893687     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01093-17     Document Type: Article
Times cited : (49)

References (12)
  • 1
    • 85014206835 scopus 로고    scopus 로고
    • Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections
    • 28 December
    • Shields RK, Chen L, Cheng S, Chavda KD, Press EG, Snyder A, Pandey R, Doi Y, Kreiswirth BN, Nguyen MH, Clancy CJ. 28 December 2016. Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections. Antimicrob Agents Chemother https://doi.org/10.1128/AAC.02097-16.
    • (2016) Antimicrob Agents Chemother
    • Shields, RK1    Chen, L2    Cheng, S3    Chavda, KD4    Press, EG5    Snyder, A6    Pandey, R7    Doi, Y8    Kreiswirth, BN9    Nguyen, MH10    Clancy, CJ.11
  • 2
    • 84995524184 scopus 로고    scopus 로고
    • Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections
    • Shields RK, Potoski BA, Haidar G, Hao B, Doi Y, Chen L, Press EG, Kreiswirth BN, Clancy CJ, Nguyen MH. 2016. Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections. Clin Infect Dis 63:1615-1618. https://doi.org/10.1093/cid/ciw636.
    • (2016) Clin Infect Dis , vol.63 , pp. 1615-1618
    • Shields, RK1    Potoski, BA2    Haidar, G3    Hao, B4    Doi, Y5    Chen, L6    Press, EG7    Kreiswirth, BN8    Clancy, CJ9    Nguyen, MH.10
  • 3
    • 85021827336 scopus 로고    scopus 로고
    • Ceftolozane-tazobactam for the treatment of multidrugresistant Pseudomonas aeruginosa infections: Clinical effectiveness and evolution of resistance
    • 25 February
    • Haidar G, Phillips NJ, Shields RK, Snyder D, Cheng S, Potoski BA, Doi Y, Hao B, Press EG, Cooper VS, Clancy CJ, Nguyen MH. 25 February 2017. Ceftolozane-tazobactam for the treatment of multidrugresistant Pseudomonas aeruginosa infections: Clinical effectiveness and evolution of resistance. Clin Infect Dis https://doi.org/10.1093/cid/cix182.
    • (2017) Clin Infect Dis
    • Haidar, G1    Phillips, NJ2    Shields, RK3    Snyder, D4    Cheng, S5    Potoski, BA6    Doi, Y7    Hao, B8    Press, EG9    Cooper, VS10    Clancy, CJ11    Nguyen, MH.12
  • 4
    • 79951507915 scopus 로고    scopus 로고
    • Multiplex real-time PCR assay for detection and classification of Klebsiella pneumoniae carbapenemase gene (bla KPC) variants
    • Chen L, Mediavilla JR, Endimiani A, Rosenthal ME, Zhao Y, Bonomo RA, Kreiswirth BN. 2011. Multiplex real-time PCR assay for detection and classification of Klebsiella pneumoniae carbapenemase gene (bla KPC) variants. J Clin Microbiol 49:579 -585. https://doi.org/10.1128/JCM.01588-10.
    • (2011) J Clin Microbiol , vol.49 , pp. 579-585
    • Chen, L1    Mediavilla, JR2    Endimiani, A3    Rosenthal, ME4    Zhao, Y5    Bonomo, RA6    Kreiswirth, BN.7
  • 7
    • 84901246678 scopus 로고    scopus 로고
    • Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneu- moniae strains with various ompK36 genotypes
    • Clancy CJ, Hao B, Shields RK, Chen L, Perlin DS, Kreiswirth BN, Nguyen MH. 2014. Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneu- moniae strains with various ompK36 genotypes. Antimicrob Agents Chemother 58:3521-3525. https://doi.org/10.1128/AAC.01949-13.
    • (2014) Antimicrob Agents Chemother , vol.58 , pp. 3521-3525
    • Clancy, CJ1    Hao, B2    Shields, RK3    Chen, L4    Perlin, DS5    Kreiswirth, BN6    Nguyen, MH.7
  • 8
    • 85018158691 scopus 로고    scopus 로고
    • Mutations in blaKPC-3 that confer ceftazidime-avibactam resistance encode novel KPC-3 variants that function as extended-spectrum betalactamases
    • 24 April
    • Haidar G, Clancy CJ, Shields RK, Hao B, Cheng S, Nguyen MH. 24 April 2017. Mutations in blaKPC-3 that confer ceftazidime-avibactam resistance encode novel KPC-3 variants that function as extended-spectrum betalactamases. Antimicrob Agents Chemother https://doi.org/10.1128/AAC .02534-16.
    • (2017) Antimicrob Agents Chemother
    • Haidar, G1    Clancy, CJ2    Shields, RK3    Hao, B4    Cheng, S5    Nguyen, MH.6
  • 10
    • 84940937491 scopus 로고    scopus 로고
    • Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum _-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenemresistant K. pneumoniae
    • 13 July
    • Shields RK, Clancy CJ, Hao B, Chen L, Press EG, Iovine NM, Kreiswirth BN, Nguyen MH. 13 July 2015. Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum _-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenemresistant K. pneumoniae. Antimicrob Agents Chemother https://doi.org/10.1128/AAC.00548-15.
    • (2015) Antimicrob Agents Chemother
    • Shields, RK1    Clancy, CJ2    Hao, B3    Chen, L4    Press, EG5    Iovine, NM6    Kreiswirth, BN7    Nguyen, MH.8
  • 11
    • 84879355307 scopus 로고    scopus 로고
    • Verification of antimicrobial susceptibility testing methods: A practical approach
    • Patel JB, Novak-Weekley S. 2013. Verification of antimicrobial susceptibility testing methods: A practical approach. Clin Microbiol Newsl 35: 103-109. https://doi.org/10.1016/j.clinmicnews.2013.06.001.
    • (2013) Clin Microbiol Newsl , vol.35 , pp. 103-109
    • Patel, JB1    Novak-Weekley, S.2
  • 12
    • 85008350884 scopus 로고    scopus 로고
    • Comparison of Etest to broth microdilution for testing of susceptibility of Pseudomonas aeruginosa to ceftolozane-tazobactam
    • Flynt LK, Veve MP, Samuel LP, Tibbetts RJ. 2017. Comparison of Etest to broth microdilution for testing of susceptibility of Pseudomonas aeruginosa to ceftolozane-tazobactam. J Clin Microbiol 55:334 -335. https://doi.org/10.1128/JCM.01920-16.
    • (2017) J Clin Microbiol , vol.55 , pp. 334-335
    • Flynt, LK1    Veve, MP2    Samuel, LP3    Tibbetts, RJ.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.